Aurélien Vidal
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Rheumatology top 10%
- Bone Tumor Diagnosis and Treatments
- Osteoarthritis Treatment and Mechanisms
Papers in
-
- Radiopharmaceutical Chemistry and Applications 26
- Rheumatology 13
- Bone Tumor Diagnosis and Treatments 7
- Osteoarthritis Treatment and Mechanisms 5
- Co-authors
- Jean‐Michel Chezal (24 shared papers)Philippe Auzeloux (20 shared papers)Jean‐Claude Madelmont (11 shared papers)Nicole Moins (9 shared papers)Emmanuelle Mounetou (3 shared papers)Elisabeth Miot-Noirault (12 shared papers)Mickaël Bourgeois (6 shared papers)Elisabeth Miot‐Noirault (10 shared papers)
In The Last Decade
Aurélien Vidal
36 papers receiving 523 citations
Peers
Comparison fields: 5 of 59
- Radiology, Nuclear Medicine and Imaging 250
- Rheumatology 102
- Genetics 37
- Cancer Research 45
- Cell Biology 29
Countries citing papers authored by Aurélien Vidal
This map shows the geographic impact of Aurélien Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien Vidal more than expected).
Fields of papers citing papers by Aurélien Vidal
This network shows the impact of papers produced by Aurélien Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien Vidal. The network helps show where Aurélien Vidal may publish in the future.
Co-authors
The 25 scholars most cited alongside Aurélien Vidal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 63 | |
| 2 | 2015 | 46 | |
| 3 | 2019 | 40 | |
| 4 | 2019 | 27 | |
| 5 | 2007 | 23 | |
| 6 | 2012 | 22 | |
| 7 | 2013 | 22 | |
| 8 | 2014 | 21 | |
| 9 | 2007 | 20 | |
| 10 | 2009 | 20 | |
| 11 | 2011 | 20 | |
| 12 | 2014 | 19 | |
| 13 | 2011 | 18 | |
| 14 | 2006 | 17 | |
| 15 | 2016 | 16 | |
| 16 | 2011 | 14 | |
| 17 | 2008 | 13 | |
| 18 | 2015 | 11 | |
| 19 | 2009 | 9 | |
| 20 | 2011 | 9 |
About Aurélien Vidal
Aurélien Vidal is a scholar working on Radiology, Nuclear Medicine and Imaging, Rheumatology, Biomaterials, Cancer Research and Cell Biology, having authored 36 papers that have together received 533 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (26 papers), Bone Tumor Diagnosis and Treatments (7 papers), Osteoarthritis Treatment and Mechanisms (5 papers), Nanoparticle-Based Drug Delivery (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Synthesis of heterocyclic compounds (1 paper) and Protease and Inhibitor Mechanisms (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (250 citations), Rheumatology (102 citations), Genetics (37 citations), Cancer Research (45 citations) and Cell Biology (29 citations). Aurélien Vidal has collaborated with scholars based in France, Greece and Poland. Frequent co-authors include Jean‐Michel Chezal, Philippe Auzeloux, Jean‐Claude Madelmont, Nicole Moins, Emmanuelle Mounetou, Elisabeth Miot-Noirault, Mickaël Bourgeois, Elisabeth Miot‐Noirault, Michel Chérel and Sophie Besse. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, European Journal of Medicinal Chemistry, Journal of Nuclear Medicine, Journal of Medicinal Chemistry and EJNMMI Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.